Long-term follow-up of PCO in three different IOLs

Article

As the population is living for longer after cataract surgery, Dr Kugelberg and colleagues believed that a longer follow-up period was required to determine PCO rates in three different IOLs. Here, she discusses the highlights of this study.

Related Videos
Esen K. Akpek, MD, Professor at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, converses via zoom with David Hutton of Ophthalmology Times
Ana Neves, head of global marketing for ZEISS Meditec Ophthalmology
Kasperi Kankare at the iCare booth at ESCRS
Scott D Barnes, MD, CMO of STAAR Surgical
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Greg Kunst, CEO of Aurion Biotech
Related Content
Carbomer-containing gels from Aacarb, Aacomer and Puroptics could be at risk of contamination. Images courtesy of MHRA.

MHRA issues safety recall for dry eye gel treatments

November 28th 2023
Article

The carbomer-containing eye gels carry risk of microbial contamination, the regulatory agency warned

Rob Thornhill, CEO, Centricity Vision, at AAO 2023

AAO 2023: Company updates from Centricity Vision CEO Rob Thornhill

November 28th 2023
Article

At this year's American Academy of Ophthalmology meeting in San Francisco, California, Rob Thornhill, CEO of Centricity Vision, spoke with the Ophthalmology Times team about developments in the company's ZEPTOLink IOL positioning systems.

An illustration of a punctal plug. A caption says the tapered tip is 0.25 mm wide and the bulk of the plug is 0.6 mm wide, which results in the ability to insert the plug into most punctal openings.

New shape for an old device: A punctal plug that better fits into the punctum

November 17th 2023
Article

Larger 0.6-mm temporary plug features a tapered edge

A photo of downtown London. Image credit: ©zgphotography – stock.adobe.com

MHRA issues UK marketing approval for Biocon Biologics biosimilar aflibercept (YESAFILI®)

November 13th 2023
Article

The company received marketing authorisation approval in the EU earlier this year

EMA recommends approval of high-dose intravitreal aflibercept (Eylea®) 8mg for nAMD and macular oedema

EMA recommends approval of high-dose intravitreal aflibercept (Eylea®) 8mg for nAMD and macular oedema

November 13th 2023
Article

The endorsement follows FDA approval in the United States this summer

A beam of energy strikes an upturned dish or lens. Image credit: ©ckybe – stock.adobe.com

Capsulotomy creation equally safe using the manual or energy-based method

November 8th 2023
Article

A study demonstrates corneal endothelial cell density measured postoperatively does not differ whether the capsulotomy was performed using continuous curvilinear capsulorhexis (CCC) or precision pulse capsulotomy (PPC)

© 2023 MJH Life Sciences

All rights reserved.